Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OTU domain-containing protein 5 (OTUD5, also known as DUBA) is a deubiquitinating enzyme that modulates protein stability and signaling in immune cells. It directly regulates ubiquitination of key adaptor proteins (notably STING and TRAF3), promoting the stability of proteins involved in antiviral and antitumor immune responses or attenuating inflammatory signaling via TLR and RLR pathways. OTUD5 is essential for robust type I interferon signaling and can regulate T-cell responses, apoptosis via TP53, and the regulation of IL-17 production. While OTUD5 is recognized as a regulatory node in immunity and tumor biology, the “novel transcript, antisense to OTUD5” (ENSG00000303123) is not a validated molecular target and lacks functional annotations or clinical relevance in current databases. All curated biological data in this entry relates to the canonical OTUD5 gene, as the queried antisense transcript is uncharacterized with no established biological, therapeutic, or pharmacological importance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OTU domain-containing protein 5 (OTUD5).